Anew Medical, Inc.
Anew Medical, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic par… Read more
Market Cap & Net Worth: Anew Medical, Inc. (WENA)
Anew Medical, Inc. (NASDAQ:WENA) has a market capitalization of $7.40 Million ($7.40 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #31717 globally and #10445 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Anew Medical, Inc.'s stock price $0.35 by its total outstanding shares 21263500 (21.26 Million).
Anew Medical, Inc. Market Cap History: 2022 to 2024
Anew Medical, Inc.'s market capitalization history from 2022 to 2024. Data shows change from $214.02 Million to $7.40 Million (-72.93% CAGR).
Anew Medical, Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Anew Medical, Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of WENA by Market Capitalization
Companies near Anew Medical, Inc. in the global market cap rankings as of March 19, 2026.
Key companies related to Anew Medical, Inc. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Anew Medical, Inc. Historical Marketcap From 2022 to 2024
Between 2022 and today, Anew Medical, Inc.'s market cap moved from $214.02 Million to $ 7.40 Million, with a yearly change of -72.93%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | $7.40 Million | -96.75% |
| 2023 | $227.52 Million | +6.31% |
| 2022 | $214.02 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 18th, 2025 the market cap of Anew Medical, Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $7.40 Million USD |
| MoneyControl | $7.40 Million USD |
| MarketWatch | $7.40 Million USD |
| marketcap.company | $7.40 Million USD |
| Reuters | $7.40 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.